TRIM21 Antibody [G17P6]

N.º de catálogo F0964

Imprimir

Descripción biológica

Especificidad

TRIM21 Antibody [G17P6] detecta niveles endógenos de proteína TRIM21 total.

Antecedentes TRIM21, también conocida como proteína de motivo tripartito 21 o Ro52, es un miembro de la familia de proteínas TRIM (motivo tripartito), caracterizada por una arquitectura de dominio conservada que comprende un dedo RING, uno o dos dominios B-box, una región coiled-coil y un dominio PRYSPRY (B30.2) C-terminal. TRIM21 es una E3 ubiquitin ligase de tipo RING, implicada en la vía de ubiquitinación que gobierna la degradación de proteínas, la señalización y la regulación inmunitaria. El dominio RING coordina iones de zinc y media la interacción con enzimas conjugadoras de Ubiquitin E2, catalizando la transferencia de Ubiquitin. El dominio B-box2, que adopta un plegamiento similar al dominio RING y también coordina el zinc, presenta una región superficial expuesta probablemente implicada en interacciones proteína-proteína, incluida la regulación intramolecular a través de la unión al dominio RING. El dominio PRYSPRY es crítico para el reconocimiento del sustrato y las funciones inmunitarias, comprendiendo dos subdominios que forman bolsillos de unión para los dominios CH2 y CH3 de la región Fc de IgG. Los residuos clave como I253 en el dominio PRYSPRY son esenciales para la unión de Fc de alta afinidad, lo que permite que TRIM21 funcione como un receptor de anticuerpos citosólico. Esto permite que TRIM21 reconozca patógenos recubiertos de anticuerpos dentro del citosol, dirigiéndolos para la ubiquitinación y la degradación proteasomal, vinculando eficazmente la inmunidad humoral adaptativa con los mecanismos de defensa innata intracelulares. TRIM21 también regula la señalización inflamatoria mediante la ubiquitinación de factores de transcripción como los factores reguladores de interferón (IRF). La desregulación de TRIM21 está implicada en enfermedades autoinmunes como el lupus eritematoso sistémico y el síndrome de Sjögren.

Información de uso

Aplicación WB, IP, IHC Dilución
WB IP IHC
1:1000 1:50 1:100 - 1:400
Reactividad Human
Fuente Rabbit Monoclonal Antibody MW 50 kDa
Tampón de almacenamiento PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
Almacenamiento
(Desde la fecha de recepción)
-20°C (avoid freeze-thaw cycles), 2 years
IHC
Experimental Protocol:
 
Deparaffinization/Rehydration
1. Deparaffinize/hydrate sections:
2. Incubate sections in three washes of xylene for 5 min each.
3. Incubate sections in two washes of 100% ethanol for 10 min each.
4. Incubate sections in two washes of 95% ethanol for 10 min each.
5. Wash sections two times in dH2O for 5 min each.
6.Antigen retrieval: For Citrate: Heat slides in a microwave submersed in 1X citrate unmasking solution until boiling is initiated; continue with 10 min at a sub-boiling temperature (95°-98°C). Cool slides on bench top for 30 min.
 
Staining
1. Wash sections in dH2O three times for 5 min each.
2. Incubate sections in 3% hydrogen peroxide for 10 min.
3. Wash sections in dH2O two times for 5 min each.
4. Wash sections in wash buffer for 5 min.
5. Block each section with 100–400 µl of blocking solution for 1 hr at room temperature.
6. Remove blocking solution and add 100–400 µl primary antibody diluent in to each section. Incubate overnight at 4°C.
7. Remove antibody solution and wash sections with wash buffer three times for 5 min each.
8. Cover section with 1–3 drops HRPas needed. Incubate in a humidified chamber for 30 min at room temperature.
9. Wash sections three times with wash buffer for 5 min each.
10. Add DAB Chromogen Concentrate to DAB Diluent and mix well before use.
11. Apply 100–400 µl DAB to each section and monitor closely. 1–10 min generally provides an acceptable staining intensity.
12. Immerse slides in dH2O.
13. If desired, counterstain sections with hematoxylin.
14. Wash sections in dH2O two times for 5 min each.
15. Dehydrate sections: Incubate sections in 95% ethanol two times for 10 sec each; Repeat in 100% ethanol, incubating sections two times for 10 sec each; Repeat in xylene, incubating sections two times for 10 sec each.
16. Mount sections with coverslips and mounting medium.
 
WB
Experimental Protocol:
 
Sample preparation
1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail),and homogenize the tissue at a low temperature.
2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) and put the sample on ice for 5 min.
3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) and put the sample on ice for 5 min.
4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
5. Remove a small volume of lysate to determine the protein concentration;
6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.
 
Electrophoretic separation
1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 10%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
 
Transfer membrane
1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications
Recommended conditions for wet transfer: 200 mA, 120 min.
( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
 
Block
1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
2. Incubate the film in the blocking solution for 1 hour at room temperature;
3. Wash the film with TBST for 3 times, 5 minutes each time.
 
Antibody incubation
1. Use 5% skim milk powder to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:1000), gently shake and incubate with the film at 4°C overnight;
2. Wash the film with TBST 3 times, 5 minutes each time;
3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
 
Antibody staining
1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system.

Referencias

  • https://pubmed.ncbi.nlm.nih.gov/17400754/
  • https://pubmed.ncbi.nlm.nih.gov/28753623/

Datos de aplicación

WB

Validado por Selleck

  • F0964-wb
    Lane 1: HeLa, Lane 2: HeLa (hIFN-α1, 10 ng/ml, 16 h)